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Abstract
Monocyte cells are exposed to a range of reactive oxygen species (ROS) when they are recruited to a site of inflammation. In this study,
we have examined the damage caused to the monocyte-like cell line U937 by peroxyl radicals and characterised the protective effect of the
macrophage synthesised compound 7,8-dihydroneopterin.
Exposure of U937 cells to peroxyl radicals, generated by the thermolytic breakdown of 2,2V-azobis(amidinopropane) dihydrochloride
(AAPH), resulted in the loss of cell viability as measured by thiazolyl blue (MTT) reduction, and lactate dehydrogenase (LDH) leakage. The
major form of cellular damage observed was cellular thiol loss and the formation of reactive protein hydroperoxides. Peroxyl radical
oxidation of the cells only caused a small increase in cellular lipid oxidation measured. Supplementation of the media with increasing
concentrations of 7,8-dihydroneopterin significantly reduced the cellular thiol loss and inhibited the formation of the protein hydroperoxides.
High performance liquid chromatography (HPLC) analysis showed 7,8-dihydroneopterin was oxidised by both peroxyl radicals and
preformed protein hydroperoxides to predominately 7,8-dihydroxanthopterin.
The possibility that 7,8-dihydroneopterin is a cellular antioxidant protecting macrophage proteins during inflammation is discussed.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Cellular inflammation involves the release of a wide
range of chemicals including reactive oxygen species
(ROS). Activated neutrophils generate superoxide, hydro-
gen peroxide and hypochlorite as part of the inflammatory
response [1,2]. Oxidation of cellular components also leads
to the formation of additional ROS, such as hydroperoxides
and chloramines, within the inflammatory lesion. The main
site of inflammatory ROS generation is the phagosome, but
ROS are also released into the extracellular environment,
causing damage to the host’s immune cells. It is into this
oxidative environment that monocyte/macrophage cells are
recruited. Entry into this oxidative environment should
require an increase in the monocyte/macrophage cell’s
antioxidant capacity.
A number of studies have suggested pterins could act as
endogenous cellular antioxidants and that 7,8-dihydroneop-
terin may be generated by macrophage cells as part of a
cellular defense mechanism during inflammation [3–7].
7,8-Dihydroneopterin is synthesised from intracellular
GTP when macrophage cells are primed with g-interferon
(IFN-g) [8,9]. IFN-g treatment of neutrophil and macro-
phage cells increases the strength of the superoxide-gener-
ating respiratory burst when the cells are activated by
exposure to mimics of bacterial infection such as zymosan.
Oxidation of 7,8-dihydroneopterin produces a number of
different products including the highly fluorescent com-
pound neopterin [3]. The measurement of neopterin in
plasma and urine has been used clinically for a number of
years as a marker of immune cell activation in vivo. Plasma
concentrations of neopterin increase with increasing T-cell
release of IFN-g during inflammatory events [10–13].
During HIV infections, the increase in 7,8-dihydroneopterin
has been shown to parallel that of neopterin [14].
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The exact function of 7,8-dihydroneopterin synthesis
during immune cell activation is undetermined, but we have
shown that 7,8-dihydroneopterin is a potent antioxidant;
inhibiting; low density lipoprotein oxidation [6], red blood
cell lysis by peroxyl radicals and hydrogen peroxide [15],
oxidation of tyrosine to dityrosine in red blood cells [15],
loss of cell viability in U937 cells exposed to hydrogen
peroxide, hypochlorite, iron and hydrogen peroxide [16],
HOCl loss of cellular tyrosine [16], and peroxyl radical- and
hydroxyl radical-mediated protein hydroperoxide formation
on serum albumin [17]. Other studies have shown 7,8-
dihydroneopterin inhibits superoxide generation [18], chlor-
omine-T cell toxicity [19], inhibits cellular chemilumines-
cence [3] and reacts rapidly with peroxyl radicals [20].
Our previous studies suggested that 7,8-dihydroneopterin
would be an effective antioxidant in protecting macrophage
cells from peroxyl radical-mediated damage. Peroxyl radi-
cals could be expected to form in vivo from lipid and
protein oxidation reactions. In this study, we have exposed
the human monocyte-like cell line U937 to peroxyl radicals
generated by the thermolytic degradation of 2,2V-azobis(a-
midinopropane) dihydrochloride (AAPH). AAPH has been
used extensively over the years as a predictable and control-
lable source of free radicals that are physiologically relevant
to biological systems [21,22]. As part of this study, we have
also characterised the toxicity of AAPH on U937 cells and
identified possible key cellular targets which are protected
by 7,8-dihydroneopterin.
We have limited the length of time the cells are exposed
to the AAPH to 12 h. This restriction has allowed us to
investigate the initial key forms of cellular damage. Incubat-
ing the cells for longer periods of time would allow
activation of cellular repair mechanisms or apoptosis.
2. Material and methods
7,8-Dihydroneopterin, 7,8-dihydroxanthopterin and neo-
pterin were obtained from Schirck’s Laboratories, Switzer-
land. MTT (thiazolyl blue) and xylenol orange were
supplied by Sigma Chemical Company (USA). AAPH
was supplied by Aldrich Chemical Company Inc. All other
reagents were of AR grade or better and obtained from BDH
Chemicals N.Z. or from Sigma. Tissue culture media and
plasticware were supplied from Gibco (USA) through Life
Technologies (N.Z.). All solutions were prepared using ion-
exchanged ultrafiltered water prepared in a NANOpure
ultrapure water system from Barnstead/Thermolyne (Iowa,
USA). Phosphate buffers were stirred with chelex-100 resin
supplied by BioRad (N.Z.) to remove contaminating heavy
metal ions. Before use, the resin was washed with NANO-
pure water to remove unbound chelator.
U937 cells were grown and maintained at 37 jC under
5% CO2 and 95% air in RPMI 1640 with phenol red
supplemented with 2 mM glutamine, 5% heat-inactivated
foetal calf serum and 100 IU/ml penicillin and 100 Ag/ml
streptomycin. All cell experiments involving AAPH-medi-
ated oxidation were conducted in Earles Balanced Salt
Solution (EBSS) to minimise interference from oxidation
products of the media. Cells were prepared for experiments
by washing twice in phosphate buffered saline (PBS) to
remove the culture media before suspension in EBSS. Cell
incubations were carried out in six-well plates with 6 ml
of cells per well at a final concentration of 5 106 cells/ml.
7,8-Dihydroneopterin and AAPH stock solutions were pre-
pared in EBSS solution on the day of experimentation and
added to the wells to give the indicated final required
concentration. Aged AAPH was prepared by incubating
500 mM AAPH at 37 jC for 10 days in the presence of air.
For all experiments, 7,8-dihydroneopterin was added to
the cells 10 min before the addition of AAPH, to allow
interaction with the cellular membranes [6]. This was
necessary to obtain maximum antioxidant activity. 7,8-
Dihydroneopterin is relatively light-sensitive, so solutions
were protected from light during preparation and all incu-
bations were performed in the dark.
Cell viability measurements by MTT reduction were
carried out using the method of Mosmann [23] but using
5% w/v SDS (final concentration) to lyse the cells and
solubilise the insoluble MTT-formazan salt. Lactate dehy-
drogenase (LDH) release from cells was measured by
monitoring the enzymatic reduction of NADH at 340 nm
[24]. Trypan blue dye exclusion was also used to monitor
cell viability [24].
Cellular thiol content was determined by the reaction
with 5,5V-dithiobis (2-nitrobenzoic acid) (DTNB) and meas-
urement of the coloured thiol anion at 412 nm [25]. Cell
suspensions were first washed with cold PBS and lysed in
SDS (5% final concentration) with sonication. Thiol con-
centration was calculated using an extinction coefficient of
1.36 104 M 1 cm 1 [25].
Lipid peroxidation was measured as thiobarbituric acid
(TBA) reactive substances (TBARS) by derivatisation with
TBA and analysed by reverse phase high performance liquid
chromatography (HPLC) with fluorescence detection [26].
Further lipid oxidation during analysis was prevented by the
addition of butylated hydroxytoluene [27] and the cellular
proteins were removed by precipitation with 10% trichloro-
acetic acid (TCA) after the TBA derivatisation step.
Cellular protein hydroperoxides were measured as pre-
viously described using a modified FOX assay [28], where
the cellular proteins are first precipitated with TCA before
suspension in acid. Briefly, cells were washed in PBS before
lysis in water and sonicated for 15 s. The cellular protein was
precipitated with TCA (final TCA concentration 5% w/v).
After centrifugation the protein pellets were washed twice
with 5% TCA, before suspension in 900-Al 25 mM H2SO4.
To the protein suspension was added 50 Al each of 5 mM
ferrous ammonium sulfate and xylenol orange in 25 mM
H2SO4. The mixture was incubated at room temperature for
30 min in the dark before centrifugation to remove cellular
debris. The hydroperoxides were assayed by their ability to
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oxidise ferrous ions to ferric ions. The ferric ions form a
coloured complex with xylenol orange which is measured by
absorbance at 560 nm, using water to zero the spectropho-
tometer [29,30].
7,8-Dihydroneopterin oxidation was monitored by reverse
phase HPLC on a C18 column developed with 5% methanol
10 mM ammonium phosphate pH 6, using electrochemical
and fluorescence detection as previous described [15].
Statistical analysis of the data was performed using
Statistica software package (StatSoft Inc., USA). Compar-
isons among treatments were performed using one-way
analysis of variance (ANOVA). In experiments that were
time-dependent, two-way analysis of variance (MANOVA)
was applied. When significance was observed (PV 0.05),
Turkey’s multiple comparison test was performed to deter-
mine which means differed from the control by a significant
margin. Levels of significance are indicated above data
points in the figures where (*) indicates P < 0.05, (**)
indicates P < 0.01, and (***) indicates P < 0.005. Results
shown are from single experiments, representative of a
minimum of three. The data points shown in the figures
are the means and standard errors of triplicate treatments.
3. Results
Exposure of U937 cells to increasing AAPH concentra-
tions drastically reduced cell viability as measured by the
MTT reduction assay (Fig. 1). The increasing AAPH con-
centration gave a exponential decrease in cell viability.
Based on these data, we chose to use 10 mM AAPH for
further characterisation of the cellular toxicity, as this
concentration gave approximately 50% reduction in U937
cell viability.
The cellular toxicity of AAPH is traditionally ascribed to
the generation of the peroxyl radical, but control experi-
ments using aged AAPH showed that the breakdown prod-
ucts of AAPH were even more toxic to the cells (Table 1).
Treatment of the aged AAPH with ascorbate greatly reduced
the cellular toxicity of the AAPH, while having no signifi-
cant effect on fresh AAPH. Ascorbic acid has been shown to
break down hydroperoxides [31].
Pre-incubation of the U937 cells with increasing concen-
trations of 7,8-dihydroneopterin caused a significant
increase in cell viability during AAPH exposure as meas-
ured by the MTT reduction and the LDH leakage assays
(Fig. 2). AAPH incubations containing 50 AM 7,8-dihydro-
Fig. 1. Loss of U937 cell viability during incubation with AAPH. U937 cells
in EBSS were incubated with a range of AAPH concentrations for 12 h
before measurement of cell viability by the MTT reduction assay. Data are
expressed as percentage of viability of the control cells with no AAPH.
Table 1
Ascorbate decreases cellular toxicity of ‘‘Aged’’ AAPH on U937 cells
Treatment Viability (% of
untreated control)
AAPH 23F 1
AAPH+ ascorbate treatment 19F 2
Aged AAPH 13F 2
Aged AAPH+ ascorbate treatment 47F 4
Freshly made AAPH and AAPH aged at 37 jC for 10 days was treated in
the presence or absence of a 1:1 molar ratio of ascorbic acid. After
treatment, excess ascorbic acid was removed with ascorbate oxidase. Cells
were incubated with the AAPH treatments (with ascorbic acid removed) for
12 h. Cell viability was measured by the ability of cells to metabolise MTT
in fresh media, following exposure to AAPH. Data are expressed as a
percentage of viability of the control cells (no AAPH).
Fig. 2. 7,8-Dihydroneopterin increases AAPH treated cell viability. U937
cells were preincubated with a range of 7,8-dihydroneopterin concen-
trations before the addition of 10 mM AAPH. After 12 h, cell viability was
measured by the ability of cells to metabolise MTT (.) and the leakage of
LDH enzyme into the media (o). Data are expressed as percentage of
viability of the control cells (no AAPH).
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neopterin significantly decreased LDH leakage from the cell
membranes but had no effect on the level of MTT reduction
until a concentration of 100 AM 7,8-dihydroneopterin was
used. At a concentration of 200 AM 7,8-dihydroneopterin,
the AAPH-mediated release of cellular LDH was com-
pletely inhibited but MTT reduction activity only returned
to 50% of the control cells’ activity. In the absence of
AAPH, 7,8-dihydroneopterin had no effect on cell viability
at any of the concentrations used.
Treatment of U937 cells with 10 mM AAPH caused a
small 50 pmol/mg increase in HPLC-TBARS. The presence
of 7,8-dihydroneopterin failed to have any significant effect
on the AAPH mediated lipid peroxidation (Table 2). Time
course studies over 22 h failed to show any significant effect
of 7,8-dihydroneopterin on the AAPH-mediated TBARS
levels at any of the time points measured. The decrease in
TBARS in the presence of 50 AM 7,8-dihydroneopterin,
compared with the control, was not statistically significant.
Our previous studies on red blood cells and U937 cells
also failed to show a significant effect on lipid oxidation
with AAPH [15,16,28].
AAPH treatment reduced the U937 cells’ thiol levels
by 25% compared to the control cells. This AAPH-
mediated thiol loss was reduced to only 7% in the
presence of 200 AM 7,8-dihydroneopterin (Fig. 3). The
inhibition of the thiol loss with increasing 7,8-dihydro-
neopterin concentrations was almost linear, suggesting a
direct scavenging of the peroxyl radical by 7,8-dihydro-
neopterin. Control experiments showed 7,8-dihydroneop-
terin had no effect on cellular thiol concentrations in the
absence of AAPH, nor could 7,8-dihydroneopterin reduce
oxidised cysteine residues. Treatment of bovine serum
albumin with sodium borohydride or h-mercaptoethanol
increases the amount of free thiol detected by DTNB
(after gel filtration to remove the reducing agents) but
7,8-dihydroneopterin treatment was unable to increase the
level of detectable thiol in serum albumin or in cellular
proteins. This suggested that the 7,8-dihydroneopterin was
preventing the thiol loss by scavenging the ROS oxidising
the thiols, rather than regenerating oxidised thiol groups
or breaking disulfide bonds.
We have previously shown that peroxyl radical exposure
to cells results in the formation of hydroperoxides on the
cellular proteins [28]. 7,8-Dihydroneopterin inhibited
AAPH-mediated cellular protein hydroperoxide formation,
Table 2
7,8-Dihydroneopterin has no significant effect on AAPH-mediated cell
lipid peroxidation
[7,8-Dihydroneopterin] (AM) Lipid oxidation TBARS
(nmol/mg cell protein)
0 287F 27
50 253F 8
100 258F 3
200 259F 0.5
U937 cells were pre-incubated with a range of 7,8-dihydroneopterin
concentrations before the addition of 10 mM AAPH. After 12 h, the level of
lipid peroxidation was measured by TBARS analysis as described.
Fig. 3. Effect of 7,8-dihydroneopterin on cellular thiol concentrations. Cells
were pre-incubated with a range of 7,8-dihydroneopterin concentrations for
10 min before a 12-h incubation period with 10 mM AAPH. Samples were
analysed for total cellular thiol levels using DTNB as described. Control
cells without AAPH treatment had a thiol concentration of 1.05 Amol/106
cells.
Fig. 4. 7,8-Dihydroneopterin protects cellular membranes from AAPH
mediated protein hydroperoxide formation. U937 cells at a concentration of
5 106 cells/ml in EBSS were pre-incubated with a range of 7,8-
dihydroneopterin concentrations for 10 min before a 12-h incubation
period with 10 mM AAPH. Samples were analysed for protein hydro-
peroxide formation using the modified FOX assay.
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with complete inhibition occurring with 200 AM 7,8-dihy-
droneopterin (Fig. 4). The inhibition was almost linear, with
linear regression analysis returning an r2 value of 0.9776.
Control experiments showed 7,8-dihydroneopterin had no
affect on the FOX assay, as it was removed during acid
precipitation of the proteins.
The near-linear relationship between 7,8-dihydroneop-
terin concentration and the inhibition of protein oxidation
suggested a direct reaction between 7,8-dihydroneopterin
and the AAPH peroxyl radicals. HPLC analysis confirmed
this reaction and identified 7,8-dihydroxanthopterin was the
major oxidation product with only 3% of the 7,8-dihydro-
neopterin being oxidised to neopterin. At 37 jC, in chelex-
treated phosphate buffer, pH 7.4, 50 AM 7,8-dihydroneop-
terin is oxidised by 1 mM AAPH at a rate of 100 nM
min 1.
7,8-Dihydroneopterin was found to react with and
degrade protein hydroperoxides. Increasing 7,8-dihydro-
neopterin concentration caused a exponential loss of pre-
formed protein hydroperoxide in bovine serum albumin
over 1 h (Fig. 5). This was in contrast to the near-linear
inhibition by 7,8-dihydroneopterin of protein hydroperoxide
formation with AAPH (Fig. 4). The differences in the effect
of 7,8-dihydroneopterin on protein hydroperoxide concen-
trations between the two experiments supports the view that
7,8-dihydroneopterin is protecting the cells by scavenging
the AAPH peroxyl radical.
4. Discussion
Proteins and thiols appear to be primary sites of
AAPH peroxyl radical damage in U937 cells during the
12-h incubations. Protein hydroperoxides, rather than
lipid hydroperoxides, appeared to be one of the main
reaction products. The addition of 7,8-dihydroneopterin to
the AAPH treated cells inhibited LDH leakage (Fig. 2),
partially restored the MTT reduction activity (Fig. 2),
inhibited thiol loss (Fig. 3) and inhibited protein hydro-
peroxide formation. Though the same trend was seen
with all the assays, cell viability measured by MTT
reduction showed the least response to 7,8-dihydroneop-
terin treatment. This was in contrast to the total restora-
tion of cell viability suggested by the LDH assay (Fig.
2). The leakage of cytosolic LDH from the cell due to
the loss of plasma membrane integrity is a marker of
gross structural damage to the cell [32]. Cellular MTT
reduction requires maintenance of the cellular NADPH/
NADP + ratio via the pentose phosphate pathway [23].
Changes in the cellular metabolism will have a major
effect on the cell’s ability to reduce MTT. This may
explain why the MTT reduction assay was more sensitive
to oxidative damage than the LDH leakage assay.
Initially, we were concerned about the possibility that
AAPH breakdown products might be more toxic than the
peroxyl radicals initially formed. Treatment of cells with
aged AAPH showed this to be the case, since aged AAPH
reduced the cell viability as much as the same concentration
of fresh AAPH (Table 1). It is well known that AAPH
thermolytic decay generates nitrogen gas and a carbon-
centered radical (RS) which rapidly combines with oxygen
to give the peroxyl radical [1]. The main product of the
AAPH peroxyl radical decay appears to be a hydroperoxide,
as ascorbate treatment drastically reduced the toxicity of the
‘‘aged’’ AAPH. Though toxic to the cells, the AAPH
hydroperoxide is less damaging than the AAPH peroxyl
radical. Over a 10-h incubation with 10 mM AAPH, the
cells were only exposed to 114 AM of peroxyl radicals
(Kd = 3.19 107 M s 1[33]) yet this radical flux reduced
the cell viability to almost the same level seen using AAPH-
hydroperoxide generated over the course of 10 days.
The classical view of free radical damage to the cell
involves lipid peroxidation of the plasma membrane. We
found lipid peroxidation to be a minor cellular event in
U937 cells, with 7,8-dihydroneopterin having no significant
effect on the reaction (Table 2). We could not find any
correlation between the concentration of TBARS and the
level of cell viability. Previous studies by ourselves and
others on red blood cells [15,34], and synaptic plasma
membranes [35] have also failed to show lipid oxidation
having any influence on cellular viability. We have observed
lipid oxidation in iron-treated U937 cells which could be
inhibited by 7,8-dihydroneopterin but treatment with hydro-
gen peroxide failed to cause significant lipid oxidation [16].
Much of the emphasis on lipid oxidation found in the
Fig. 5. Reduction of protein hydroperoxides by 7,8-dihydroneopterin.
Bovine serum albumin at 2 mg/ml was incubated with 10 mM AAPH for 2
h at 37 jC. The protein was precipitated and washed with 5% w/v
trichloroacetic acid (final concentration) before suspension in sodium
phosphate buffer pH 7.4. 7,8-Dihydroneopterin was added to the oxidised
protein solution and incubated for 1 h at 37 jC. Protein hydroperoxide
concentration was measured using the modified FOX assay.
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literature may stem from studies on the polyunsaturated
fatty acid (PUFA)-rich lipoproteins. PUFA-rich lipoproteins
easily oxidise via a lipid peroxyl radical-mediated chain
reaction which can be inhibited by 7,8-dihydroneopterin
scavenging of the lipid peroxyl radical [6]. In contrast,
cellular membranes have a relatively high protein content
and low PUFA content, making the protein the most likely
target of free radical damage [36]. The inhibitory effect of
proteins on lipid peroxidation has been demonstrated
recently using protein containing liposomes [37].
The apparent dominance of free radical scavenging by
the cellular proteins results in the formation of reactive
protein hydroperoxides within the actual cells [28]. Unlike
protein carbonyls, protein hydroperoxides are reasonably
reactive and will cross-link DNA [38], oxidise cellular thiols
[39] and consume key biomolecules [36] such as the
antioxidants ascorbate and glutathione [31]. 7,8-Dihydro-
neopterin was very effective at inhibiting protein hydro-
peroxide formation in both cells exposed to AAPH (Fig. 4)
and proteins (bovine serum albumin) exposed to either
AAPH or X-ray radiolysis hydroxyl radicals [17]. To date,
7,8-dihydroneopterin is the first antioxidant shown to inhibit
protein hydroperoxide formation.
A number of ROS have been shown to cause loss of
cellular thiols [2], including AAPH [35]. Cellular calcium
homeostasis is disrupted by hydrogen peroxide and AAPH
through the oxidation of cellular thiols [35,40] and carbonyl
formation [35]. Protein hydroperoxides have also been
shown to oxidise glutathione, the major cellular thiol in
the cytoplasm [31]. This suggests that both the AAPH
peroxyl radicals and protein hydroperoxides are responsible
for the observed 25% loss of the cellular thiols (Fig. 3). This
level of thiol loss will have a major impact on the redox
potentials within the cell and may further explain why the
MTT cell viability assay appeared so sensitive to AAPH
treatment. Glutathione is maintained in a reduced state by
the oxidation of NADPH. The cellular demand for regener-
ation of glutathione may affect the cell’s ability to reduce the
MTT. We found 7,8-dihydroneopterin was unable to reduce
oxidised thiols in protein samples pre-treated with AAPH
but very effective at preventing thiol loss in the U937 cells
exposed to AAPH (Fig. 3).
7,8-Dihydroneopterin is a very effective scavenger of
peroxyl radicals [6], with a rate constant of 107 M s 1 [20].
This reaction rate suggests the observed inhibition of cell
viability loss, protein hydroperoxide formation and thiol
loss due to direct scavenging of the peroxyl radical by 7,8-
dihydroneopterin. It was interesting to note that 7,8-dihy-
droneopterin was able to react with and degrade the protein
hydroperoxides on proteins (Fig. 5). This reaction seemed
much slower than the reaction with the peroxyl radical, but
may still be of significance in vivo where high radical fluxes
during respiratory burst may overwhelm antioxidant defense
mechanisms. Respiratory burst activity in neutrophils has
been shown to cause carbonyl formation on the neutrophils
cellular proteins [41].
It appears that 7,8-dihydroneopterin may associate with
the cell membrane, as a short incubation period with the
cells was required before the addition of the oxidant to
obtain reproducible, concentration-dependent results. We
have also observed this phenomena while studying 7,8-
dihydroneopterin antioxidant activity with red blood cells,
lipoproteins and pure proteins [6,15,17]. This association
would place 7,8-dihydroneopterin on or near the biological
site to be protected. This is similar in principle to the
mechanism by which a-tocopherol protects cellular mem-
branes by dissolving in the lipid phase. Since 7,8-dihydro-
neopterin is relatively stable over the pre-incubation period,
it is unlikely that the observed antioxidant effects and the
requirement for this pre-incubation are due to the formation
of radical scavenging breakdown products.
The major product of 7,8-dihydroneopterin oxidation by
both AAPH peroxyl radicals and protein hydroperoxides is
7,8-dihydroxanthopterin, with only a small amount of neo-
pterin being formed. 7,8-Dihydroxanthopterin is formed by
the loss of the trihydroxypropropyl side chain attached to
carbon-6 of 7,8-dihydroneopterin. This may occur through a
retro-aldol reaction and could be initiated by the abstraction
of a hydrogen from the middle carbon hydroxyl group on the
7,8-dihydroneopterin side chain. Neopterin formation
involves proton abstraction from carbon-7 and nitrogen-8 to
give neopterin [6]. This reaction appears to dominate when
7,8-dihydroneopterin is exposed to HOCl [16,42,43]. HOCl
is also released during inflammatory response by neutrophils
[44].
We are unaware of any studies reporting the measurement
of 7,8-dihydroxanthopterin in vivo, though assuming 7,8-
dihydroxanthopterin is also in the same nanomolar concen-
trations as neopterin, it will be difficult to detect using HPLC-
based electrochemical detection. HPLC measurements of
plasma neopterin rely on neopterin’s extremely strong fluo-
rescence [9]. It is possible that during inflammation, a
significant amount of the pterin synthesised by macrophages
is oxidised to 7,8-dihydroxanthopterin but not detected. The
majority of the pterin in plasma is 7,8-dihydroneopterin [9].
Whether there is enough 7,8-dihydroneopterin to provide
antioxidant protection to macrophages in vivo remains to be
determined. Pterin plasma concentrations are reported to be in
the high nanomolar range during inflammation [9]. This is
below the micromolar concentration of 7,8-dihydroneopterin
required for radical scavenging or activation of apoptosis,
which requires millimolar concentrations of 7,8-dihydro-
neopterin [45]. The neopterin and 7,8-dihydroneopterin
measured in plasma are thought to originate from inflamma-
tory sites, so the pterins measured must have been diluted in
the plasma from sites of much higher concentrations.
The clinical data on neopterin/7,8-dihydroneopterin
release in the plasma, the fact that IFN-g acts to prime
immune cells during inflammation, and the observed anti-
oxidant properties of 7,8-dihydroneopterin support our
hypothesis that this pterin functions to protect macrophage
cells from oxidants released during inflammation.
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